FDA: Mercury Risk Means Certain People Should Not Get Amalgam Dental Fillings
Recommendation was issued after a review of research, monitoring reports, and public discussions
U.S. Non-English Speakers Less Likely to Have SARS-CoV-2 Test
Seattle study shows non-English speakers less likely to complete testing but more likely to test positive
Chinese Company Says Its COVID-19 Vaccine Should Be Available in U.S. in Early 2021
If it passes final round of human tests, SinoVac will apply to the FDA to sell CoronaVac vaccine
United First U.S. Airline to Offer COVID-19 Testing for Passengers
Rapid test at airport provides results in about 20 minutes and will cost $250
Survey: Rheumatic Diseases Pose Routine Challenges
Patient survey shows challenges with affordability, activity limitations, mental health
Public Awareness Low for Invasive Fungal Diseases
Awareness varies from 4.1 percent for blastomycosis to 24.6 percent for candidiasis
FDA Requiring Labeling Changes to Benzodiazepine Prescribing Information
Update to Boxed Warning must include risks for abuse, misuse, addiction, physical dependence, withdrawal reaction
Guidelines Updated for Managing Dyslipidemia to Cut CVD Risk
Moderate-dose statin therapy recommended for patients with 10-year CVD risk ≥12 percent
Cognition-Enhancing Supplements May Contain Unapproved Drugs
Five unapproved pharmaceutical drugs ID'd in supplements marketed to improve memory, cognition
Teens’ Mental Illness Treatment May Not Follow Guidelines
Variance in treatment occurs within and across ZIP codes, suggesting non-supply-side variables
